High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D
High sensitivity C-reactive protein levels were associated with recurrent cardiovascular events in patients with T2D and history of recent acute coronary syndrome.
In the AWARD-7 trial, patients who received Trulicity 0.75mg or 1.5mg in combination with mealtime insulin lispro achieved similar glycemic control with weight loss vs patients who received traditional basal-bolus ...
Results showed the overall safety profile of linagliptin in study patients, including adults with kidney disease, was consistent with previous data.
Adjustment of glucose-lowering medications in patients who are at high-risk for severe hypoglycemia may be beneficial to prevent mild cognitive impairment.